Minimum Investment
₹129,000
Price Range
₹41 to ₹43
Lot Size
3000 shares
Issue Size
₹12 Cr
About the Company
Goldline Pharmaceuticals is engaged in the business of marketing pharmaceutical products under the brand name “Goldline.”
Bookbuilding IPO
IPO Objectives
- Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our company
- General corporate purposes
Important Dates
| Bid/Offer Opens On | 12-05-2026 |
| Bid/Offer Closes On | 14-05-2026 |
| Finalisation of Basis of Allotment | 15-05-2026 |
| Initiation of Refunds | 18-05-2026 |
| Credit of Shares to Demat | 18-05-2026 |
| IPO Listing Date | 19-05-2026 |
IPO Subscription Status
| Category | Offered Shares | Applied Shares | Times |
|---|---|---|---|
| QIB | 540,000 | 97,317,000 | 180.22x |
| NII | 390,000 | 648,333,000 | 1,662.39x |
| NII ( >10 lakh) | 260,000 | 518,874,000 | 1,995.67x |
| NII ( <10 lakh) | 130,000 | 129,459,000 | 995.84x |
| Retail | 900,000 | 793,038,000 | 881.15x |
| Total | 1,830,000 | 1,538,688,000 | 840.81x |
Frequently asked questions
What is the Goldline Pharmaceutical IPO (Bse Sme) IPO lot size?
The lot size is 3000 shares with a minimum investment of ₹129,000.
When does the Goldline Pharmaceutical IPO (Bse Sme) IPO open and close?
Bidding is scheduled from 12-05-2026 to 14-05-2026 (subject to exchange updates).
How can I apply for the Goldline Pharmaceutical IPO (Bse Sme) IPO?
You can apply via the IPO Focuss - Ambica Finstock LLP mobile app during the bidding window using UPI or ASBA as available for this issue.
What is the Goldline Pharmaceutical IPO (Bse Sme) IPO listing date?
Shares are expected to list on 19-05-2026 (tentative; confirm from RHP / exchange notices).
Grey Market Premium (GMP)
—
Registrar
Bigshare Services Pvt.Ltd.
Lead Managers
- Cumulative Capital Pvt.Ltd.
Company Promoters
- Amol Laxmikant Mujumdar and Swapan Premprakash Khandelwal are the company promoters.
